There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The Food and Drug Administration just announced that it will immediately start using AI across all of its centers, after ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

Food and Drug Administration Director Martin Makary announced the agency-wide deployment of an artificial intelligence tool ...